IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024
IFF Pharma Solutions is showcasing its 75-year legacy as an excipient manufacturer at CPHI 2024 in Milan, October 8-10. The company is unveiling new product launches and technologies, including:
1. Low nitrite excipient solutions for nitrosamine risk mitigation, such as Avicel® PH Low Nitrite (LN) and METHOCEL™ products.
2. Ultrapure alginate technologies for biotechnology, including NOVAMATRIX-3D™ and PRONOVA® UP CAM.
3. New foil bag-in-box packaging for POLYOX™ water-soluble resins, extending stability and supporting sustainability initiatives.
These innovations aim to address critical industry challenges and support pharmaceutical and biotech advancements.
IFF Pharma Solutions presenta il suo patrimonio di 75 anni come produttore di eccipienti al CPHI 2024 a Milano, dal 8 al 10 ottobre. L'azienda svelerà nuovi lanci di prodotti e tecnologie, tra cui:
1. Soluzioni di eccipienti a basso nitrito per la mitigazione del rischio di nitrosamine, come Avicel® PH Low Nitrite (LN) e prodotti METHOCEL™.
2. Tecnologie di alginato ultrapuro per la biotecnologia, tra cui NOVAMATRIX-3D™ e PRONOVA® UP CAM.
3. Nuovi packaging in busta con sacco interno per le resine idrosolubili POLYOX™, che prolungano la stabilità e supportano iniziative di sostenibilità.
Queste innovazioni mirano a risolvere le sfide critiche dell'industria e a supportare i progressi nel settore farmaceutico e biotecnologico.
IFF Pharma Solutions está exhibiendo su legado de 75 años como fabricante de excipientes en CPHI 2024 en Milán, del 8 al 10 de octubre. La empresa presentará nuevos lanzamientos de productos y tecnologías, incluyendo:
1. Soluciones de excipientes con bajo contenido de nitrito para la mitigación del riesgo de nitrosaminas, como Avicel® PH Low Nitrite (LN) y productos METHOCEL™.
2. Tecnologías de alginato ultrapuro para biotecnología, incluyendo NOVAMATRIX-3D™ y PRONOVA® UP CAM.
3. Nuevo empaquetado tipo bolsa en caja para las resinas solubles en agua POLYOX™, que extienden la estabilidad y apoyan iniciativas de sostenibilidad.
Estas innovaciones buscan abordar desafíos críticos de la industria y apoyar los avances farmacéuticos y biotecnológicos.
IFF Pharma Solutions는 75년 전통을 가진 이국품 제조업체로서 CPHI 2024에서 10월 8일부터 10일까지 밀라노에서 공연합니다. 이 회사는 다음과 같은 신제품 출시와 기술을 공개합니다:
1. 질산염 저감 솔루션인 Avicel® PH Low Nitrite (LN)과 METHOCEL™ 제품을 포함하여 니트로사민 위험 완화를 위한 솔루션.
2. 생명공학을 위한 초순수 알지네이트 기술인 NOVAMATRIX-3D™와 PRONOVA® UP CAM.
3. 폴리옥스™ 수용성 수지에 대한 새로운 포장 재단, 안정성을 연장하고 지속 가능성 이니셔티브를 지원합니다.
이러한 혁신은 산업의 중요한 도전에 대응하고 제약 및 생명공학 발전을 지원하는 것을 목표로 하고 있습니다.
IFF Pharma Solutions met en avant son héritage de 75 ans en tant que fabricant d'excipients lors du CPHI 2024 à Milan, du 8 au 10 octobre. L'entreprise dévoilera de nouveaux lancements de produits et technologies, y compris :
1. Solutions d'excipients à faible nitrite pour la mitigation des risques de nitrosamines, comme Avicel® PH Low Nitrite (LN) et les produits METHOCEL™.
2. Technologies d'alginates ultrapurs pour la biotechnologie, y compris NOVAMATRIX-3D™ et PRONOVA® UP CAM.
3. Nouvel emballage en foil bag-in-box pour les résines hydrosolubles POLYOX™, prolongeant la stabilité et soutenant les initiatives de durabilité.
Ces innovations visent à relever des défis critiques de l'industrie et à soutenir les avancées pharmaceutiques et biotechnologiques.
IFF Pharma Solutions präsentiert sein 75-jähriges Erbe als Excipient-Hersteller auf der CPHI 2024 in Mailand, vom 8. bis 10. Oktober. Das Unternehmen wird neue Produkteinführungen und Technologien vorstellen, darunter:
1. Niedernitrit-Excipient-Lösungen zur Minderung des Nitroasaminrisikos, wie Avicel® PH Low Nitrite (LN) und METHOCEL™ Produkte.
2. Ultrapure Alginat-Technologien für die Biotechnologie, einschließlich NOVAMATRIX-3D™ und PRONOVA® UP CAM.
3. Neue Foil Bag-in-Box-Verpackungen für wasserlösliche POLYOX™ Harze, die Stabilität verlängern und Nachhaltigkeitsinitiativen unterstützen.
Diese Innovationen zielen darauf ab, kritische Herausforderungen der Branche anzugehen und den Fortschritt in der Pharma- und Biotechnologie zu unterstützen.
- Launching new low nitrite excipient solutions for nitrosamine risk mitigation
- Introducing ultrapure alginate technologies for biotechnology applications
- Implementing new packaging for POLYOX™ water-soluble resins, extending product stability
- New packaging reduces landfill waste by more than 85% compared to fiber drums
- None.
"We are unveiling groundbreaking technologies that refine polymer expertise, tackling critical industry challenges head-on and empowering our customers to achieve unparalleled success," said Angela Strzelecki, President, Pharma Solutions, IFF. "As we mark over 75 years of market leadership as a market leading excipient manufacturer, we invite visitors to join us to witness this transformative journey with us."
Low nitrite excipient solutions
Nitrosamine risk mitigation will take center stage at booth 6B10, where IFF will unveil its expanding portfolio of solutions for nitrosamine control. Avicel® PH Low Nitrite (LN) is a range of low nitrite microcrystalline cellulose (MCC) grades demonstrated to reduce the risk of nitrosamine formation as part of broader mitigation strategies. IFF's expertise in this space also extends to its well-established METHOCEL™ family of products. The Company will spotlight how its advanced analytical method leverages highly sensitive ion chromatography-mass spectrometry (IC/MS) to detect nitrites at trace levels down to parts per billion (ppb) in its METHOCEL™ grades. Furthermore, attendees can look forward to an exclusive preview of IFF's upcoming low nitrite addition.
Supporting breakthroughs in biotech
Demonstrating its contribution to the future of biotechnology, IFF will present its expanding ultrapure alginate technologies at CPHI. NOVAMATRIX-3D™, part of the NovaMatrix® product portfolio, is an animal-free 3D cell culture system engineered for efficient cell seeding and enzyme-free cell release. It offers a more physiologically relevant environment than traditional 2D cultures, supporting various cell lines and opening new possibilities for drug development, cancer research, tissue engineering, toxicity testing and stem cell research. IFF will also showcase PRONOVA® UP CAM, a specialized ultrapure calcium alginate allowing for controlled and in-situ gelation across diverse biomedical applications, from cell and drug encapsulation systems to advanced wound dressings and tissue engineering.
New horizons with POLYOX™ ES packaging
In addition to its biopolymer solutions, IFF will introduce new foil bag-in-box packaging for its POLYOX™ water-soluble resins (WSR). The packaging extends the stability of POLYOX™ WSR by providing a moisture and oxygen barrier to preserve polymer viscosity, improving the product's storage life and supporting more effective supply chain and inventory management practices. The packaging is also more easily recyclable than fiber drums providing more than 85 percent reduction in landfill waste associated with POLYOX™ WSR packaging to support customers' sustainability initiatives.
Join IFF's experts to learn how the Company's expanding capabilities continue to optimize drug product formulation and drive innovation forward, visit booth 6B10 or schedule an appointment here.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, X (Twitter) , Facebook, Instagram, and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
SOURCE IFF
FAQ
What new products is IFF Pharma Solutions launching at CPHI 2024?
How does IFF's new packaging for POLYOX™ water-soluble resins (WSR) benefit customers?
What is IFF's approach to nitrosamine risk mitigation in pharmaceuticals?
What are the applications of IFF's new ultrapure alginate technologies?
